Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems.

Stafinski T, McCabe CJ, Menon D.

Pharmacoeconomics. 2010;28(2):113-42. doi: 10.2165/11530820-000000000-00000. Review.

PMID:
20085389
2.

Access with evidence development schemes: a framework for description and evaluation.

McCabe CJ, Stafinski T, Edlin R, Menon D; Banff AED Summit..

Pharmacoeconomics. 2010;28(2):143-52. doi: 10.2165/11530850-000000000-00000.

PMID:
20085390
3.

Access with evidence development: the US experience.

Mohr PE, Tunis SR.

Pharmacoeconomics. 2010;28(2):153-62. doi: 10.2165/11531050-000000000-00000.

PMID:
20085391
4.

To fund or not to fund: development of a decision-making framework for the coverage of new health technologies.

Stafinski T, Menon D, McCabe C, Philippon DJ.

Pharmacoeconomics. 2011 Sep;29(9):771-80. doi: 10.2165/11539840-000000000-00000.

PMID:
21756008
5.

A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.

Wallner PE, Konski A.

J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008. Review.

PMID:
18954812
6.

Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.

Flynn MA, McNeil DA, Maloff B, Mutasingwa D, Wu M, Ford C, Tough SC.

Obes Rev. 2006 Feb;7 Suppl 1:7-66. Review.

PMID:
16371076
7.

Coverage with Evidence Development: applications and issues.

Trueman P, Grainger DL, Downs KE.

Int J Technol Assess Health Care. 2010 Jan;26(1):79-85. doi: 10.1017/S0266462309990882.

PMID:
20059784
8.

Health technology funding decision-making processes around the world: the same, yet different.

Stafinski T, Menon D, Philippon DJ, McCabe C.

Pharmacoeconomics. 2011 Jun;29(6):475-95. doi: 10.2165/11586420-000000000-00000. Review.

PMID:
21568357
9.
10.

Development and implementation of health technology assessment in Argentina: two steps forward and one step back.

Rubinstein A, Pichon-Riviere A, Augustovski F.

Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:260-9. doi: 10.1017/S0266462309090734.

PMID:
19527545
11.

Access with evidence development in the UK: past experience, current initiatives and future potential.

Briggs A, Ritchie K, Fenwick E, Chalkidou K, Littlejohns P.

Pharmacoeconomics. 2010;28(2):163-70. doi: 10.2165/11531410-000000000-00000.

PMID:
20085392
12.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE; American Society of Clinical Oncology..

J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183.

PMID:
19581533
13.

Coverage with evidence development: the Ontario experience.

Levin L, Goeree R, Levine M, Krahn M, Easty T, Brown A, Henry D.

Int J Technol Assess Health Care. 2011 Apr;27(2):159-68. doi: 10.1017/S0266462311000018. Review.

PMID:
21473814
14.

Procedures and methods of benefit assessments for medicines in Germany.

Bekkering GE, Kleijnen J.

Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

PMID:
18987905
15.

Cost-effectiveness analysis: from science to application.

Berger ML, Teutsch S.

Med Care. 2005 Jul;43(7 Suppl):49-53.

PMID:
16056009
17.

A common policy framework for evidence generation on promising health technologies.

Carbonneil C, Quentin F, Lee-Robin SH; European network for Health Technology Assessment (EUnetHTA)..

Int J Technol Assess Health Care. 2009 Dec;25 Suppl 2:56-67. doi: 10.1017/S0266462309990699. Review.

PMID:
20030892
18.

Public health policy decisions on medical innovations: what role can early economic evaluation play?

Hartz S, John J.

Health Policy. 2009 Feb;89(2):184-92. doi: 10.1016/j.healthpol.2008.05.011. Review.

PMID:
18619704
19.

Drug reimbursement policies in Canada--need for improved access to critical therapies.

LeLorier J, Bell A, Bougher DJ, Cox JL, Turpie AG.

Ann Pharmacother. 2008 Jun;42(6):869-73. doi: 10.1345/aph.1K373.

PMID:
18477735
20.

Introduction of emerging medical devices on the market: a new procedure in Belgium.

Vinck I, Neyt M, Thiry N, Louagie M, Ramaekers D.

Int J Technol Assess Health Care. 2007 Fall;23(4):449-54.

PMID:
17937833

Supplemental Content

Support Center